Антифосфолипидный синдром - Насонов Е.Л.
ISBN 5-98216-010-5
Скачать (прямая ссылка):
Насонов Е.Л. Антифосфолипидный синдром.
Проявления Число пациентов %
Поражение надпочечников 20 17,4%
Вены
• глубокие вены конечностей 28 24,3
• вены другой локализации 6 5,2
Артерии
• периферические 16 13,9
• аорта 3 2,6
Кожа 45 39,1
Некроз костного мозга 5 4,3
Другие необычные локализации поражения 14 12,2
* Острый респираторный дистресс-синдром взрослых
ЛИТЕРАТУРА
1. Насонов ЕЛ, Баранов АА, Шилкина НП, Алекберова ЗС. Патология сосудов при анти-фосфолипидном синдроме (клиника, диагностика, лечение). Москва—Ярославль: Типография ГТУЯрославль, 1995; 161 с.
2. Levine J, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752—763.
3. Bermas BL, Schur PH. Clinical manifestations and diagnosis of the antiphospholipid syndrome. UpToDates 2003; 12,2.
4. Galli M, Barbui T. Antiphospholipid syndrome: definition and treatment. Seminars Thromb Hemost 2003; 29: 195—203.
5. Asherson R, Cervera R. Unusual manifestations of the antiphospholipid syndrom.http:// www.rheuma21st.com.
6. Калашникова ЛА. Неврология антифосфолипидного синдрома. Москва: Медицина, 2003; 256 с.
7. Clark CA, Spitzer KA, Laskin CA. The spectrum of the antiphospholipid syndrome. J Rheumatol 2001; 28: 1939—1942.
8. Asherson R The catastrophic antiphospholipid syndrome (CAPS). http://www.rheuma21st.com.
9. Tanner D, Levine R, Kittner S. Epidemiology of antiphospholipid antibodies and vascular disease. In: Levine SR, Brey RL, eds. Clinical
Approach to Antiphospholipid Antibodies. Boston: Butterworth Heinemann 2000; 1—18.
10. Viana JL, Khamashta MA, Ordi-Ros J, et al. Compartison of the primary and secondary antiphospholipid syndrome: an European multicenter study of 131 patients. Am J Med 1994; 96: 3—9.
11. Sammaritano LR. Pediatric and familial antiphospholipid syndromes. In: Asherson RA, Cervera R, Piette JC, Shoenfeld Y. editors. The antiphospholipid syndrome. Boca Raton (FL) LCRD Press 1996; 259—266.
12. Cervera, R, Piette, JC, Font, J, et al. Anti-phospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000patients. Arthritis Rheum 2002; 46: 1019.
13. Asherson RA, Khamashta MA, Ordi-Ros J, et al. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989; 68: 366—374.
14. Alar^n-Segovia D, Perez-Vаzquez ME, Villa AR, Drenkard C, Cabiedes J. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum 1992; 21: 275—286.
15. Harris, EN, Chan, JKH, Asherson, RA, et al. Thrombosis, recurrent fetal loss, and thrombo-
SHS-OOO4.qxd 21.11.2006 16:56 Page 195
95
ГЛАВА 7. Клинические проявления антифосфолипидного синдрома
cytopenia: Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986; 146: 2153.
16. Bird AG, Lendrum R, Asherson RA, Hughes GRV. Disseminated intravascular coagulation, antiphospholipid antibodies and ischaemic necrosis of extremities. Ann Rheum Dis 1987; 46: 251— 255.
17. Asherson RA, Derksen RHWM, Harris EN et al. Large vessel occlusion and gangrene in systemic lupus erythematosus and "lupus-like" disease. A report of six cases. J Rheumatol 1986; 13: 740—747.
18. Jindal BK, Martin MFR, Gayner A. Gangrene developing after minor surgery in a patients with undiagnosed systemic lupus erythematosus and lupus anticoagulant. Ann Rheum Dis 1983; 42: 347—349.
19. Hall S, Buettner H, Luthra HS. Occlusive retinal vascular disease in systemic lupus erythe-matosus. J Rheumatol 1984; 11: 846—850.
20. Ferrante FM, Myerson GE, Goldman JA. Subclavian artery thrombosis mimicking the aortic arch syndrome in systemic lupus erythemato-sus. Arthritis Rheum 1982; 25: 1501—1504.
21. Asherson RA, Harris EN, Gharavi AE, et al. Aortic arch syndrome associated with anticardi-olipin antibodies and the lupus anticoagulant. Comment on Ferrante paper". Arthritis Rheum 1985; 28: 594—595.
22. Drew P, Asherson RA, Zuk RJ, et al. Aortic occlusion in systemic lupus erythematosus associated with antiphospholipid antibodies. Ann Rheum Dis 1987; 46: 612—616.
23. Ter Borg EJ, Van Der Meer J, De Wolf JTM et al. Arterial thrombotic manifestations in young women associated with the lupus antocoagulant. Clin Rheumatol 1988; 7: 74—79.
24. Finazzi G, Brancaccio V, Moia, M, et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the Italian registry. Am J Med 1996; 100: 530.
25. Schulman S, Svenungsson E, Granqvist, S, and the Duration of Anticoagulation Study Group. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Am J Med 1998; 104: 32.
26. Levine SR, Brey RL. Neurological aspects of antiphospholipid antibody syndrome. Lupus 1996; 5:347.
27. Sanna G, Bertolaccini ML, Cuadrado MJ, et al. Neuropsichiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. Rheumatology 2003; 30: 985—992.
